Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Gregory Cheng"'
Autor:
Dong Ji, Guo-feng Chen, Xiao-xia Niu, Mingjie Zhang, Cheng Wang, Qing Shao, Vanessa Wu, Yudong Wang, Gregory Cheng, Selwyn J. Hurwitz, Raymond F. Schinazi, George Lau
Publikováno v:
Metabolism Open, Vol 10, Iss , Pp 100090- (2021)
Background and aim: The incidence of hepatocellular carcinoma (HCC) decreases significantly in chronic hepatitis C (CHC) patients with sustained virologic response (SVR) after pegylated-interferon plus ribavirin (PR) or direct-acting antiviral (DAAs)
Externí odkaz:
https://doaj.org/article/9a948444dbf84dc0a7e00a6d6cdedda0
Autor:
Gregory Cheng, Rino Alvani Gani, Ji Dong Jia, Diana A. Payawal, Guo Feng Chen, Khin Maung Win, Simone I. Strasser, Zhen Wen Liu, Hasmik Ghazinian, Saeed Hamid, Tony Mok, Tanwandee Tawesak, Jer Ming Chang, Ann-Lii Cheng, Shiv Kumar Sarin, Jin Lin Hou, Rosmawaiti Mohamed, Pierce K. H. Chow, Grace Lai-Hung Wong, Masashi Mizokami, Patrick Lau, Woon Leung Ng, George Lau, Teerha Piratvisuth, Oidov Baatarkhuu, A. Kadir Dokmeci, Ming-Lung Yu, Alexander J. Thompson, Masao Omata, Joong-Won Park
Publikováno v:
Hepatology International
Background & Aim Hepatitis B reactivation related to the use of immunosuppressive therapy remains a major cause of liver-related morbidity and mortality in hepatitis B endemic Asia-Pacific region. This clinical practice guidelines aim to assist clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae2c6fb7be712487ce1e61ca1628353b
https://doi.org/10.1007/s12072-021-10239-x
https://doi.org/10.1007/s12072-021-10239-x
Publikováno v:
British Journal of Haematology. 189:369-378
Current first-line treatments for immune thrombocytopenia (ITP) usually have transient effects and sustained platelet response off therapy remains low. We evaluated whether eltrombopag plus pulsed dexamethasone as first-line therapy can increase the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2127160810ec85cd92f509bb09da942c
https://doi.org/10.1111/bjh.16327
https://doi.org/10.1111/bjh.16327
Autor:
Bing Zhu, Fangjiao Song, Honglin Liu, Yin Sun, Tianjiao Xu, Dongze Li, Haibo Wang, Shaojie Xin, Yudong Wang, Gregory Cheng, George Lau, Sa Lv, Shaoli You
Background Drug-induced liver injury (DILI) is one of the most serious adverse drug reactions and the incidence has been increasing rapidly. Accumulating evidence suggested that the immune activation and systemic inflammatory responses play a signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c95ea86d05099bfb0eeee481b383ec16
https://doi.org/10.21203/rs.3.rs-1116072/v1
https://doi.org/10.21203/rs.3.rs-1116072/v1
Publikováno v:
Glob Health Med
With the introduction of effective directly acting antiviral agents (DAAs) therapy, control and elimination of hepatitis C virus (HCV) infection is becoming a feasible goal. In Hong Kong, HCV prevalence in general population is 0.3%-0.5% over the pas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73c02e82e6cd6af49b2200bcac5ba02
https://pubmed.ncbi.nlm.nih.gov/34782869
https://pubmed.ncbi.nlm.nih.gov/34782869
Publikováno v:
Journal of Hepatology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb59527c1f33686d431b836230aae35
https://doi.org/10.1016/j.jhep.2020.03.044
https://doi.org/10.1016/j.jhep.2020.03.044
Publikováno v:
In Acta Biomaterialia 2009 5(1):101-114
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273444ba04db1d03599e67408f78dff6
https://pubmed.ncbi.nlm.nih.gov/33064127
https://pubmed.ncbi.nlm.nih.gov/33064127
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f05b219588084d395410218f8f2dc953
https://pubmed.ncbi.nlm.nih.gov/32474605
https://pubmed.ncbi.nlm.nih.gov/32474605
Autor:
Dawei Zhang, Dong Ji, Zhu Chen, Yudong Wang, Chen Li, George Lau, Enqiang Qin, Jinsong Mu, Peng Zhao, Jing Xu, Gregory Cheng, Tieniu Yang
Publikováno v:
Hepatology International
Background and Aim Cytokine storm has been reported in patients with coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We examine the incidence of acute on chronic liver failure (ACLF)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500da03326b485450450ebe256e994e1